Study of VVN001 Ophthalmic Solution in Dry Eye Disease
NCT04556838
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
169
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
VVN001 Ophthalmic Solution 1%
DRUG:
VVN001 Ophthalmic Solution 5%
DRUG:
Vehicle
Sponsor
VivaVision Biotech, Inc